no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children
|
Knuf, M. |
|
2010 |
28 |
3 |
p. 744-753 10 p. |
article |
2 |
A live bivalent influenza vaccine based on a H9N2 virus strain
|
Wu, Rui |
|
2010 |
28 |
3 |
p. 673-680 8 p. |
article |
3 |
Alphavirus replicon particle vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: Proof of concept
|
Erdman, M.M. |
|
2010 |
28 |
3 |
p. 594-596 3 p. |
article |
4 |
A novel assay for influenza virus quantification using surface plasmon resonance
|
Estmer Nilsson, C. |
|
2010 |
28 |
3 |
p. 759-766 8 p. |
article |
5 |
A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates
|
Bartlett, Emmalene J. |
|
2010 |
28 |
3 |
p. 767-779 13 p. |
article |
6 |
A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses
|
Hassantoufighi, Arash |
|
2010 |
28 |
3 |
p. 790-797 8 p. |
article |
7 |
Attitudes toward and intention to receive the human papilloma virus (HPV) vaccination and intention to use condoms among female Korean college students
|
Kang, Hee Sun |
|
2010 |
28 |
3 |
p. 811-816 6 p. |
article |
8 |
Comparative varicella vaccine effectiveness during outbreaks in day-care centres
|
Spackova, M. |
|
2010 |
28 |
3 |
p. 686-691 6 p. |
article |
9 |
Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model
|
Sabarth, Nicolas |
|
2010 |
28 |
3 |
p. 650-656 7 p. |
article |
10 |
Cross-neutralisation of Australian brown snake, taipan and death adder venoms by monovalent antibodies
|
Isbister, Geoffrey K. |
|
2010 |
28 |
3 |
p. 798-802 5 p. |
article |
11 |
Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial
|
Keitel, Wendy |
|
2010 |
28 |
3 |
p. 840-848 9 p. |
article |
12 |
Economic impact of the introduction of an acellular pertussis vaccine in Canada: A 6-year analysis
|
Iskedjian, Michael |
|
2010 |
28 |
3 |
p. 714-723 10 p. |
article |
13 |
Editorial Board
|
|
|
2010 |
28 |
3 |
p. CO2- 1 p. |
article |
14 |
Evaluation of a commercial bovine viral diarrhea virus vaccine in nonpregnant female alpacas (Vicugna pacos)
|
Byers, Stacey R. |
|
2010 |
28 |
3 |
p. 591-593 3 p. |
article |
15 |
Evaluation of the adjuvant properties of Astragalus membranaceus and Scutellaria baicalensis GEORGI in the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models
|
Yang, Xiaoyan |
|
2010 |
28 |
3 |
p. 737-743 7 p. |
article |
16 |
Expanding immunization coverage in rural India: A review of evidence for the role of community health workers
|
Patel, Amit R. |
|
2010 |
28 |
3 |
p. 604-613 10 p. |
article |
17 |
George Martin Baer 1936–2009
|
Wilde, Henry |
|
2010 |
28 |
3 |
p. 868- 1 p. |
article |
18 |
Hepatitis A and E: Update on prevention and epidemiology
|
FitzSimons, David |
|
2010 |
28 |
3 |
p. 583-588 6 p. |
article |
19 |
Hepatitis B vaccines: WHO position paper—Recommendations
|
|
|
2010 |
28 |
3 |
p. 589-590 2 p. |
article |
20 |
Immunity after natural exposure to enteric canine coronavirus does not provide complete protection against infection with the new pantropic CB/05 strain
|
Decaro, Nicola |
|
2010 |
28 |
3 |
p. 724-729 6 p. |
article |
21 |
Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age
|
Kaltenböck, A. |
|
2010 |
28 |
3 |
p. 834-839 6 p. |
article |
22 |
Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2–10 years of age
|
Black, S. |
|
2010 |
28 |
3 |
p. 657-663 7 p. |
article |
23 |
Immunotherapy with the saponin enriched-Leishmune® vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis
|
Borja-Cabrera, G.P. |
|
2010 |
28 |
3 |
p. 597-603 7 p. |
article |
24 |
Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old
|
Rauw, Fabienne |
|
2010 |
28 |
3 |
p. 823-833 11 p. |
article |
25 |
Incompletely matched influenza vaccine still provides protection in frail elderly
|
Dean, Anna S. |
|
2010 |
28 |
3 |
p. 864-867 4 p. |
article |
26 |
Innate immune defense in visceral leishmaniasis: Cytokine mediated protective role by allogeneic effector cell
|
Manna, Partha Pratim |
|
2010 |
28 |
3 |
p. 803-810 8 p. |
article |
27 |
Long-term protection provided by hepatitis B vaccine and need for booster dose: A meta-analysis
|
Poorolajal, Jalal |
|
2010 |
28 |
3 |
p. 623-631 9 p. |
article |
28 |
MCV vaccination in the presence of vaccine-associated Guillain–Barré Syndrome risk: A decision analysis approach
|
Cho, Bo-Hyun |
|
2010 |
28 |
3 |
p. 817-822 6 p. |
article |
29 |
Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand
|
Poovorawan, Yong |
|
2010 |
28 |
3 |
p. 730-736 7 p. |
article |
30 |
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses
|
Guy, Bruno |
|
2010 |
28 |
3 |
p. 632-649 18 p. |
article |
31 |
Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study
|
Leroux-Roels, Isabel |
|
2010 |
28 |
3 |
p. 849-857 9 p. |
article |
32 |
Recombinant A27 protein synergizes with modified vaccinia Ankara in conferring protection against a lethal vaccinia virus challenge
|
He, Yong |
|
2010 |
28 |
3 |
p. 699-706 8 p. |
article |
33 |
Reduction in hospitalizations for diarrhea and rotavirus infections in New York state following introduction of rotavirus vaccine
|
Chang, Hwa-Gan H. |
|
2010 |
28 |
3 |
p. 754-758 5 p. |
article |
34 |
Subcutaneous inoculation of a whole virus particle vaccine prepared from a non-pathogenic virus library induces protective immunity against H7N7 highly pathogenic avian influenza virus in cynomolgus macaques
|
Itoh, Yasushi |
|
2010 |
28 |
3 |
p. 780-789 10 p. |
article |
35 |
Successful seroresponses to measles and rubella following aerosolized Triviraten vaccine, but poor response to aerosolized mumps (Rubini) component: Comparisons with injected MMR
|
Diaz-Ortega, Jose Luis |
|
2010 |
28 |
3 |
p. 692-698 7 p. |
article |
36 |
Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: A clinical trial of immunogenicity in lower airways of human volunteers
|
Bumann, Dirk |
|
2010 |
28 |
3 |
p. 707-713 7 p. |
article |
37 |
The role of complement in innate and adaptive immunity to pneumococcal colonization and sepsis in a murine model
|
Bogaert, D. |
|
2010 |
28 |
3 |
p. 681-685 5 p. |
article |
38 |
The role of Toll-like receptors and C-type lectins for vaccination against Candida albicans
|
Ferwerda, Gerben |
|
2010 |
28 |
3 |
p. 614-622 9 p. |
article |
39 |
Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice
|
Alexander, Jeff |
|
2010 |
28 |
3 |
p. 664-672 9 p. |
article |
40 |
Vaccine wastage in Bangladesh
|
Guichard, Stephane |
|
2010 |
28 |
3 |
p. 858-863 6 p. |
article |